Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up

E.H. Vogelzang, E.L. Kneepkens, M.T. Nurmohamed, A.W.R. van Kuijk, T. Rispens, G. Wolbink, C.L.M. Krieckaert

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2178-2182
JournalAnnals of the Rheumatic Diseases
Issue number12
Publication statusPublished - 2014

Cite this